Talisman Wealth Advisors’s Amgen AMGN Stock Holding History

Talisman Wealth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$251K	Sell	713 -59	-8%	-$21K	0.2%	84
2025 Q4	$253K	Sell	772 -59	-7%	-$18.7K	0.2%	96
2025 Q3	$235K	Hold	831	–	–	0.19%	102
2025 Q2	$232K	Sell	831 -57	-6%	-$16.1K	0.21%	98
2025 Q1	$277K	Sell	888 -86	-9%	-$25.4K	0.28%	81
2024 Q4	$254K	Sell	974 -29	-3%	-$8.6K	0.27%	88
2024 Q3	$324K	Sell	1,003 -4	-0.4%	-$1.31K	0.34%	71
2024 Q2	$315K	Buy	1,007 +76	+8%	+$22.3K	0.36%	69
2024 Q1	$265K	Buy	931 +3	+0.3%	+$878	0.33%	77
2023 Q4	$267K	Buy	928 +14	+2%	+$3.81K	0.4%	69
2023 Q3	$246K	Sell	914 -2	-0.2%	-$499	0.43%	71
2023 Q2	$203K	Buy	916 +6	+0.7%	+$1.39K	0.35%	84
2023 Q1	$220K	Buy	910 +135	+17%	+$33.1K	0.4%	78
2022 Q4	$204K	Buy	+775	New	+$208K	0.43%	71

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Talisman Wealth Advisors's AMGN Position: Q1 2026 in Review

Talisman Wealth Advisors reduced its Amgen (AMGN) stake by 7.6% in Q1 2026, selling an estimated $21K and leaving 713 shares worth $251K. The position accounts for 0.2% of the portfolio, ranked #84.

Talisman Wealth Advisors first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $324K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Talisman Wealth Advisors held 713 shares of Amgen worth $251K as of Q1 2026.
Talisman Wealth Advisors sold 59 Amgen shares in Q1 2026, an estimated $21K.
Amgen made up 0.2% of Talisman Wealth Advisors's portfolio in Q1 2026, its #84 holding.
Talisman Wealth Advisors first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
Talisman Wealth Advisors's Amgen position peaked at $324K in Q3 2024.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Talisman Wealth Advisors's 13F filing for Q1 2026, filed 15 May 2026.